NewswireToday - /newswire/ -
Noida, Uttar Pradesh, India, 2010/07/26 - With new government incentives and policies coming into pipeline, the Indian clinical trials market is expected to grow at a CAGR of around 31% during FY 2010 – FY 2012.
According to our new research report “Booming Clinical Trials Market in India”, India is anticipated to become one of the most lucrative destinations for clinical research outsourcing in coming years. The future outlook of the Indian clinical trials market remains buoyant as it will grow at a CAGR of around 31% during the forecast period FY 2010-FY 2012. Various factor like new government incentives & policies will spur growth in the industry.
We have done thorough research and prudent analysis of the Indian clinical trials industry and identified some critical factors acting as a catalyst for the industry’s current and future growth outlook. The report reveals that the number of clinical trials in India has been rising continuously since 2005. Further, it was observed that the clinical trials in India grew at a CAGR of 50% during 2007-2009, nearly six times higher at which number of global clinical trials surged. Low cost, English based medical education, prevalence of western disease and expert medical staffs were the major drivers of the industry during this period.
Our research indicates the clinical trials market will help many allied sectors like IVD industry and educational industry to accelerate their growth pace. In addition, the market will observe opening up of many job opportunities for young professionals in the coming years.
“Booming Clinical Trials Market in India” provides detailed information about the cost associated with different clinical trials phase. It also elaborates on the contribution of government regulation in the growth of clinical trials industry in the country. Apart from this extensive research on success and risk factors for clinical trials industry has been done. Further, the report covers an in-depth analysis of various industry parameters like global clinical market trends, size and patient pool availability, infrastructure and expertise.
It also includes future outlook of various industry segments such as clinical trials, doctors, etc. with aid of effective and prudent forecasting techniques. To enable the client for better understanding of the industry, competitive landscape has been provided to derive a clear picture of the market trends and new strategies. Easy to comprehend content, detail information analysis and effective presentation are some of the main features of this report.
RNCOS (rncos.com) specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.